Atlas Trials

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Clinical trial NCT05226169 · RECRUITING

Trial details

NCT number
NCT05226169
Sponsor
Asan Medical Center
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Gastric Carcinoma
Start date
2022-04-29
Primary completion
2026-11-30
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.